头孢唑林
医学
腹膜炎
万古霉素
腹膜透析
外科
导管
麻醉
预防性抗生素
抗生素
随机对照试验
金黄色葡萄球菌
遗传学
生物
微生物学
细菌
作者
Mohamed Gadallah,G Ramdeen,Carlos Torres,Joseph Mignone,DK Patel,Lindi Mitchell,Sandra Tatro
出处
期刊:PubMed
[National Institutes of Health]
日期:2000-01-01
卷期号:16: 199-203
被引量:12
摘要
The role of vancomycin and other antibiotics in treatment of acute peritonitis in peritoneal dialysis patients is well established. However, the role of preoperative vancomycin or cephalosporins in preventing early infection in newly placed peritoneal dialysis catheters remains controversial. We performed a prospective randomized study to examine the role of vancomycin or cefazolin prophylaxis in decreasing the incidence of postoperative peritonitis. Over 8-year period, 265 patients undergoing 305 permanent peritoneal catheter placement procedures were randomized into three groups. Group I (103 procedures) received a single intravenous (i.v.) dose of 1000 mg vancomycin 12 hours before the peritoneal catheter placement procedure. Group II (102 procedures) received a single i.v. dose of 1000 mg of Ancef (cefazolin) 3 hours before the procedure. Group III (100 procedures) received no antibiotics preoperatively for a least one week before the procedure. Patients were monitored for peritonitis during the following 14 days. Peritonitis developed in 1 patient (1%) in Group I (vancomycin group) compared to 12 patients (12%) in Group III (control group), p = 0.002, and in 9 patients (9%) in Group II (cefazolin group) compared to Group III, p = 0.68. We conclude that the use of preoperative single-dose i.v. vancomycin prophylaxis for permanent peritoneal dialysis catheter placement reduces the risk of postoperative peritonitis. Cefazolin did not achieve a statistically significant difference from the control group and may not provide adequate prophylaxis.
科研通智能强力驱动
Strongly Powered by AbleSci AI